Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 16 Similar Profiles
Anticoagulants Medicine & Life Sciences
Dabigatran Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Rivaroxaban Medicine & Life Sciences
Hemorrhage Medicine & Life Sciences
Heparin Medicine & Life Sciences
Thrombin Medicine & Life Sciences
Prothrombin Time Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2010 2018

Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis

Spronk, H. M. H. , Padro, T. , Siland, J. E. , Prochaska, J. H. , Winters, J. , van der Wal, A. C. , Posthuma, J. J. , Lowe, G. , d'Alessandro, E. , Wenzel, P. , Coenen, D. M. , Reitsma, P. H. , Ruf, W. , van Gorp, R. H. , Koenen, R. R. , Vajen, T. , Alshaikh, N. A. , Wolberg, A. S. , Macrae, F. L. , Asquith, N. & 43 others Heemskerk, J., Heinzmann, A., Moorlag, M., Mackman, N., van der Meijden, P., Meijers, J. C. M., Heestermans, M., Renné, T., Dólleman, S., Chayouâ, W., Ariëns, R. A. S., Baaten, C. C., Nagy, M., Kuliopulos, A., Posma, J. J., Harrison, P., Vries, M. J., Crijns, H. J. G. M., Dudink, E. A. M. P., Buller, H. R., Henskens, Y. M. C., Själander, A., Zwaveling, S., Erküner, O., Eikelboom, J. W., Gulpen, A., Peeters, F. E. C. M., Douxfils, J., Olie, R. H., Baglin, T., Leader, A., Schotten, U., Scaf, B., van Beusekom, H. M. M., Mosnier, L. O., van der Vorm, L., Declerck, P., Visser, M., Dippel, D. W. J., Strijbis, V. J., Pertiwi, K., Ten Cate-Hoek, A. J. & Ten Cate, H. 2018 In : Thrombosis and Haemostasis. 118, 2, p. 229-250 22 p.

Research output: Contribution to journalArticle

Thromboembolism
Thrombosis
Therapeutics
Blood Platelets
Fibrin

International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants

Gosselin, R. C., Adcock, D. M., Bates, S. M., Douxfils, J., Favaloro, E. J., Gouin-Thibault, I., Guillermo, C., Kawai, Y., Lindhoff-Last, E. & Kitchen, S. 2018 In : Thrombosis and Haemostasis.

Research output: Contribution to journalArticle

Hematology
Anticoagulants
Point-of-Care Systems
Partial Thromboplastin Time
Prothrombin Time
Prothrombin Time
Anticoagulants
Erythrocytes
Extracellular Vesicles
Thrombin
Phospholipids
Erythrocyte Transfusion

Clinical pearls: Laboratory assessments of direct oral anticoagulants (DOACS)

Gosselin, R., Gosselin, R., Douxfils, J. & Adcock, D. 2017 In : Hamostaseologie. 37, 4

Research output: Contribution to journalReview article

Anticoagulants
Factor Xa
Venous Thromboembolism
Thrombin
Atrial Fibrillation

Prizes

55th ASH Annual Meeting and Exposition - Abstract Achievement Award

Jonathan Douxfils (Recipient), 7 Dec 2013

Prize: Prize (including medals and awards)

56th ASH Annual Meeting and Exposition - Abstract Achievement Award

Jonathan Douxfils (Recipient), 6 Dec 2014

Prize: Prize (including medals and awards)

58th Annual SSC Meeting of the ISTH - Young Investigators Awards

Jonathan Douxfils (Recipient), 26 Jun 2012

Prize: Prize (including medals and awards)

Prix Léo Pharma Cancer & Thrombosis

Hélène Haguet (Recipient), Jonathan Douxfils (Recipient), François Mullier (Recipient) & Jean-Michel Dogne (Recipient), 25 Feb 2017

Prize: Prize (including medals and awards)

XXIV Congress of the ISTH - Young Investigators Awards

Jonathan Douxfils (Recipient), 29 Jun 2013

Prize: Prize (including medals and awards)

Activities 2010 2018

In vitro effects of BCR-ABL TKIs on endothelial cell survival and functions

Haguet, H. (Speaker), Douxfils, J. (Speaker), Christian Chatelain (Speaker), Graux, C. (Speaker), Mullier, F. (Speaker), Dogne, J. (Speaker)
9 Feb 2018

Activity: Talk or presentationOral presentation

Réunion de Consensus INAMI/RIZIV

Douxfils, J. (Speaker)
30 Nov 2017

Activity: Talk or presentationInvited talk

Risk of vascular occlusive events with BCR-ABL TKIs in CML

Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Christian Chatelain (Speaker), Graux, C. (Speaker), Dogne, J. (Speaker)
25 Feb 2017

Activity: Talk or presentationOral presentation

BHS Course - Antithrombotic therapy

Douxfils, J. (Speaker)
10 Dec 2016

Activity: Talk or presentationInvited talk

Thrombosis Expert Academy (TEA)

Douxfils, J. (Keynote Speaker)
24 Nov 201626 Nov 2016

Activity: Participating in or organising an eventParticipation in workshop, seminar, course

Thesis

Evaluation of thrombotic and/or bleeding risks associated with anticoagulotherapy.

Author: Douxfils, J., 24 Oct 2015

Supervisor: Dogne, J. (Supervisor), Mullier, F. (Supervisor), Masereel, B. (President), Chatelain, B. (Jury), Chatelain, C. (Jury), Verhamme, P. (Jury), TEN CATE, H. (Jury) & Ageno, W. (Jury)

Student thesis: Doc typesDoctor of Biomedical and Pharmaceutical Sciences

Therapeutic monitoring of new oral anticoagulant: focus on dabigatran

Author: Douxfils, J., 2012

Supervisor: Dogne, J. (Supervisor)

Student thesis: Master typesMaster of Pharmacy

Press / Media

L'UNamur lance son labo pour combattre la thrombose

Jonathan Douxfils

6/12/17

1 media contribution

Press/Media: Research

Qualiblood combat la thrombose

Jonathan Douxfils

5/12/17

1 media contribution

Press/Media: Research

Vascular Occlusion Risk Reviewed For CML New-Generation TKIs

Jonathan Douxfils

17/02/16

1 item of media coverage

Press/Media: Expert Comment

BCR-ABL TKIs May Increase Cardiovascular Risk

Jonathan Douxfils

16/02/16

1 item of media coverage

Press/Media: Expert Comment